Monkeypox Concept(BK4583),Stock Price, Discussion, News, Quote & History - To The Moon - Tiger Brokers Online Investing Community - To The Moon

At the request of the exchanges, the U.S./Hong Kong stock quotes are displayed on a 15-minute delay, download the APP to view the real-time quotes for free.

Close

BK4583 Monkeypox Concept

Trading 11-04 15:07:07 EST

2,425.68

+87.72

+3.75%

High2,434.73	Low2,338.11	Vol38.85M
Open2,338.11	D1 Closing2,337.97	Amplitude4.13%
Mkt Cap0.00	Tradable Cap0.00	Total Shares0.00
T/O1.26B	T/O Rate--	Tradable Shares0.00
P/B2.044085	ROE--	EPS0.00
52wk High--	52wk Low--	P/E--
Dividend--	Div.Yield--	ROA--

Loading ...

{"stockData":{"symbol":"BK4583","market":"US","secType":"PLATE","nameCN":"Monkeypox Concept","latestPrice":2425.683,"timestamp":1793822827367,"preClose":2337.968,"halted":0,"volume":38853406,"delay":0,"changeRate":0.037518,"floatShares":0,"shares":0,"eps":0,"marketStatus":"Trading","change":87.715088,"latestTime":"11-04 15:07:07 EST","open":2338.1145,"high":2434.7292,"low":2338.1145,"amount":1255928328.107087,"amplitude":0.041324,"askPrice":0,"askSize":0,"bidPrice":0,"bidSize":0,"shortable":3,"etf":0,"tradingStatus":0,"nextMarketStatus":{"tag":"Post-Mkt","tradingStatus":3,"beginTime":1793826000000},"marketStatusCode":0,"adr":0,"adjPreClose":0,"pbRate":2.044085,"peRate":216.938454,"turnoverRate":0.014378,"increases":6,"decrements":4,"flats":0,"marketCap":267442103879.75,"floatMarketCap":266486373958.25},"requestUrl":"/m/hq/s/BK4583","defaultTab":"news","newsList":[{"id":"2680105747","title":"Gilead and Kite Present Blood Cancer Therapy Data at ASH Annual Meeting","url":"https://stock-news.laohu8.com/highlight/detail?id=2680105747","media":"Reuters","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2680105747?lang=en_us&edition=fundamental","pubTime":"2026-11-04 22:19","pubTimestamp":1793801985,"startTime":"0","endTime":"0","summary":"Gilead and Kite Present Blood Cancer Therapy Data at ASH Annual MeetingGilead Sciences and Kite will attend the 68th American Society of Hematology Annual Meeting and Exposition on December 12-15, 202","market":"sg","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20261104:nNDL15vCqR:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["IBB","IE00BZ1G4Q59.USD","LU1037948541.HKD","LU2324357040.USD","LU0965508806.USD","LU0122379950.USD","LU2468319806.SGD","BK4588","BK4578","BBH","LU1571399168.USD","BMED","LU1778281490.HKD","LU1934455277.USD","LU0320765992.SGD","BK4583","LU0859254822.USD","MEDI","SG9999015945.SGD","TMED","IE00BSNM7G36.USD","IBBQ","LU1236620750.USD","LU0234570918.USD","LU0965509283.SGD","LU2087621335.USD","BIB","GILD","BK4532","LU1585245621.USD","LU0882574055.USD","TBXU","LU1674673428.USD","LU1037948897.HKD","IE00BKVL7J92.USD","LU1057294990.SGD","BK4566","LU1061106388.HKD","LU0109394709.USD","LU0823416689.USD","BK4550","LU2112291526.USD","BK4139","LU0965509101.SGD","SG9999015952.SGD","LU1236620834.HKD","IE0002270589.USD","LU0861579265.USD","LU0114720955.EUR","IE00B19Z3581.USD"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2680057472","title":"Gilead to Present 18-Month Anito-Cel Trial Follow-up Data in Multiple Myeloma at ASH 2026","url":"https://stock-news.laohu8.com/highlight/detail?id=2680057472","media":"Reuters","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2680057472?lang=en_us&edition=fundamental","pubTime":"2026-11-04 22:19","pubTimestamp":1793801951,"startTime":"0","endTime":"0","summary":"Gilead to Present 18-Month Anito-cel Trial Follow-Up Data in Multiple Myeloma at ASH 2026Gilead Sciences and Kite will present 23 abstracts, including seven oral presentations, at ASH on December 12-1","market":"other","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20261104:nNDL7pmdGs:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["MEDI","LU1061106388.HKD","LU1674673428.USD","TMED","LU1037948541.HKD","BK4585","SG9999015978.USD","BK4550","LU2112291526.USD","LU2357627491.SGD","LU0965508806.USD","LU0114720955.EUR","LU1934455194.USD","SG9999015952.SGD","LU0109394709.USD","BBH","SG9999015945.SGD","LU1057294990.SGD","LU1023059063.AUD","LU0965509101.SGD","IE00B7SZLL34.SGD","LU0859254822.USD","IE00BKVL7J92.USD","LU1934455277.USD","LU0320765992.SGD","LU2468319806.SGD","GILD","IBBQ","LU0889565916.HKD","LU1066051498.USD","LU1236620750.USD","LU0965509010.AUD","LU1037948897.HKD","LU2324357040.USD","LU2089984988.USD","IE00B19Z3581.USD","IBB","BK4583","LU0965509283.SGD","TBXU","BIB","LU0882574055.USD","LU2087621335.USD","LU0861579265.USD","LU1236620834.HKD","LU1571399168.USD","BMED","LU0234570918.USD","IE0002270589.USD","BK4532"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2680169057","title":"Gilead and Kite Advance Leadership with New Data Across Pipeline and Portfolio at Ash 2026","url":"https://stock-news.laohu8.com/highlight/detail?id=2680169057","media":"THOMSON REUTERS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2680169057?lang=en_us&edition=fundamental","pubTime":"2026-11-04 22:15","pubTimestamp":1793801700,"startTime":"0","endTime":"0","summary":null,"market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20261104:nTUA5YRSNY:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"reuters_en_live","symbols":["LU1236620750.USD","LU1934455277.USD","MEDI","LU0882574055.USD","IE00B7SZLL34.SGD","IE00BZ1G4Q59.USD","SG9999015952.SGD","LU1571399168.USD","TBXU","IBBQ","LU1778281490.HKD","IE00BSNM7G36.USD","BK4583","LU2087621335.USD","BK4585","LU0320765992.SGD","LU0289739699.SGD","LU0861579265.USD","LU1037948541.HKD","IE00B19Z3581.USD","BK4532","BIB","LU0859254822.USD","LU1236620834.HKD","LU1430594728.SGD","SG9999015978.USD","BK4568","LU2468319806.SGD","LU0965509101.SGD","TMED","BBH","IBB","LU0823416689.USD","LU1839511570.USD","LU0234570918.USD","LU2324357040.USD","IE00BKVL7J92.USD","GILD","LU1037948897.HKD","LU1585245621.USD","LU0122379950.USD","BMED","SG9999015945.SGD","BK4550","LU2089984988.USD","LU1057294990.SGD","BK4588","LU0965509010.AUD","BK4566","IE00B19Z3B42.SGD"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2680055764","title":"Tonix Pharmaceuticals Presents at Guggenheim's Healthcare Innovation Conference","url":"https://stock-news.laohu8.com/highlight/detail?id=2680055764","media":"Reuters","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2680055764?lang=en_us&edition=fundamental","pubTime":"2026-11-04 20:12","pubTimestamp":1793794350,"startTime":"0","endTime":"0","summary":"Tonix Pharmaceuticals Presents at Guggenheim's Healthcare Innovation ConferenceTonix Pharmaceuticals will attend Guggenheim’s 3rd Annual Healthcare Innovation Conference in Boston on Nov. 10, 2026.CEO","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20261104:nNDL4lRgqT:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["IE00BN0W2W23.USD","IE00BKPKM429.USD","IE00BN0W2T93.GBP","IE00BGHQF748.EUR","LU2095319765.USD","IE00BQXX3C00.GBP","LU0314104364.USD","SG9999014039.USD","BK4588","BK4112","IE00BN0W2V16.EUR","NDAQ","IE00BQXX3D17.EUR","LU2210149790.SGD","BCDF","IE00B3QW5Z07.USD","SG9999014005.SGD","SG9999014021.USD","LU2210150020.SGD","BK4583","IE00BQXX3F31.USD","TNXP","IE00B64PRP62.GBP","BK4139","BK4585","SG9999014013.SGD"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2680205315","title":"Viatris Declares Quarterly Dividend of $0.12 Per Share","url":"https://stock-news.laohu8.com/highlight/detail?id=2680205315","media":"Reuters","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2680205315?lang=en_us&edition=fundamental","pubTime":"2026-11-04 19:59","pubTimestamp":1793793587,"startTime":"0","endTime":"0","summary":"Viatris Declares Quarterly Dividend of $0.12 Per ShareViatris declared a quarterly dividend of $0.12 per common share on November 2, 2026.The dividend is payable December 16, 2026, to shareholders of ","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20261104:nNDL8Dtgfm:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["LU2087621335.USD","BK4588","VTRS","BK4007","BK4583","LU1839511570.USD","BK4585"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2680053357","title":"Inovio Pharmaceuticals Inc. Stock Underperforms Tuesday When Compared to Competitors","url":"https://stock-news.laohu8.com/highlight/detail?id=2680053357","media":"Dow Jones","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2680053357?lang=en_us&edition=fundamental","pubTime":"2026-11-04 06:24","pubTimestamp":1793744640,"startTime":"0","endTime":"0","summary":"DJ Inovio Pharmaceuticals Inc. Stock Underperforms Tuesday When Compared To CompetitorsThis article was automatically generated by MarketWatch using technology from Automated Insights.Shares of Inovio Pharmaceuticals Inc.  plunged 12.17% to $1.66 Tuesday, on what proved to be an all-around mixed trading session for the stock market, with the NASDAQ Composite Index  rising 0.83% to 25,372.01 and the Dow Jones Industrial Average  falling 0.38% to 51,786.72.Inovio Pharmaceuticals Inc. closed 38.97% short of its 52-week high of $2.72, which the company achieved on December 17th.The stock underperformed when compared to some of its competitors Tuesday, as Johnson & Johnson  fell 1.62% to $266.17, Statera Biopharma Inc.  remained unchanged, and Pfizer Inc.  fell 2.18% to $30.00.Trading volume  eclipsed its 50-day average volume of 9.5 M.Data source: Dow Jones Market Data, FactSet. Data compiled November 3, 2026.","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":["rate"],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://dowjonesnews.com/newdjn/logon.aspx?AL=N","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4568","BK4139","BK4583","INO"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2680703562","title":"Quest Diagnostics Inc. Stock Underperforms Tuesday When Compared to Competitors","url":"https://stock-news.laohu8.com/highlight/detail?id=2680703562","media":"Dow Jones","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2680703562?lang=en_us&edition=fundamental","pubTime":"2026-11-04 06:00","pubTimestamp":1793743200,"startTime":"0","endTime":"0","summary":"DJ Quest Diagnostics Inc. Stock Underperforms Tuesday When Compared To CompetitorsThis article was automatically generated by MarketWatch using technology from Automated Insights.Shares of Quest Diagnostics Inc.  slid 1.50% to $247.06 Tuesday, on what proved to be an all-around mixed trading session for the stock market, with the S&P 500 Index  rising 0.36% to 7,568.92 and the Dow Jones Industrial Average  falling 0.38% to 51,786.72.This was the stock's third consecutive day of losses.Quest Diagnostics Inc. closed 3.86% short of its 52-week high of $256.99, which the company achieved on October 30th.The stock underperformed when compared to some of its competitors Tuesday, as UnitedHealth Group Inc.  rose 1.00% to $404.44, IQVIA Holdings Inc.  rose 1.61% to $262.59, and Centene Corp.  rose 1.43% to $67.48.Trading volume  eclipsed its 50-day average volume of 1.1 M.Data source: Dow Jones Market Data, FactSet. Data compiled November 3, 2026.","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":["rate"],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://dowjonesnews.com/newdjn/logon.aspx?AL=N","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4196","BK4585","BK4567","LU2506951958.HKD","BK4583","BK4588","LU0823417737.USD","LU2506952097.USD","LU0950375773.USD","LU1854103824.USD","LU0823417653.USD","LU2506952170.USD","LU2506951875.HKD","DGX","LU1854104046.USD"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2680088137","title":"Gilead Sciences Inc. Stock Underperforms Tuesday When Compared to Competitors","url":"https://stock-news.laohu8.com/highlight/detail?id=2680088137","media":"Dow Jones","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2680088137?lang=en_us&edition=fundamental","pubTime":"2026-11-04 05:34","pubTimestamp":1793741640,"startTime":"0","endTime":"0","summary":"DJ Gilead Sciences Inc. Stock Underperforms Tuesday When Compared To CompetitorsThis article was automatically generated by MarketWatch using technology from Automated Insights.Shares of Gilead Sciences Inc.  slipped 1.68% to $167.47 Tuesday, on what proved to be an all-around mixed trading session for the stock market, with the S&P 500 Index  rising 0.36% to 7,568.92 and the Dow Jones Industrial Average  falling 0.38% to 51,786.72.This was the stock's second consecutive day of losses.Gilead Sciences Inc. closed 4.66% short of its 52-week high of $175.65, which the company achieved on October 30th.The stock demonstrated a mixed performance when compared to some of its competitors Tuesday, as Johnson & Johnson  fell 1.62% to $266.17, Pfizer Inc.  fell 2.18% to $30.00, and Abbott Laboratories  fell 0.69% to $109.40.Trading volume  eclipsed its 50-day average volume of 6.0 M.Data source: Dow Jones Market Data, FactSet. Data compiled November 3, 2026.","market":"other","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":["rate"],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://dowjonesnews.com/newdjn/logon.aspx?AL=N","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["GILD","SG9999015952.SGD","LU2087621335.USD","LU2324357040.USD","LU1674673691.USD","LU0320765992.SGD","LU0965509283.SGD","IBBQ","IE00B19Z3B42.SGD","LU1037948541.HKD","IE0002270589.USD","TMED","LU1066051498.USD","SG9999015945.SGD","LU0289739699.SGD","BK4588","LU0058720904.USD","LU1934455277.USD","LU2468319806.SGD","MEDI","BK4585","TBXU","LU1839511570.USD","LU2357627491.SGD","LU0823416689.USD","LU0965509010.AUD","LU1934455863.HKD","LU1057294990.SGD","LU1066053197.SGD","LU1236620750.USD","LU0889565916.HKD","LU1061106388.HKD","LU2112291526.USD","IBB","IE00B19Z3581.USD","SG9999015978.USD","LU0122379950.USD","BK4583","BK4578","BK4550","LU0109394709.USD","LU1778281490.HKD","BK4568","LU0234570918.USD","IE00BKVL7J92.USD","LU0859254822.USD","LU1023059063.AUD","BK4566","IE00BZ1G4Q59.USD","LU1430594728.SGD","LU1674673428.USD","SG9999015986.USD","LU1037948897.HKD","LU1934455194.USD","LU1585245621.USD","BIB","BBH","IE00B7SZLL34.SGD","LU1571399168.USD","BMED","IE00BSNM7G36.USD","LU0114720955.EUR","LU0861579265.USD","LU1236620834.HKD","BK4532","LU2089984988.USD","LU0882574055.USD","LU0965508806.USD","LU0965509101.SGD","BK4139","IE00B3T34201.USD"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2680508779","title":"Why Gilead Sciences (GILD) Is Back In The Spotlight","url":"https://stock-news.laohu8.com/highlight/detail?id=2680508779","media":"Simply Wall St.","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2680508779?lang=en_us&edition=fundamental","pubTime":"2026-11-04 01:22","pubTimestamp":1793726566,"startTime":"0","endTime":"0","summary":"Gilead Sciences (GILD) just turned a strong third quarter into a louder statement. An earnings beat linked to HIV treatments, a higher HIV growth outlook and a fresh record share price have pulled renewed attention to the stock.\nThat reaction sits on top of a powerful run. Gilead Sciences has delivered a 40.07% year to date share price return and a 25.94% 90 day share price gain. The 5 year total shareholder return of 208.52% points to momentum that has been building over several years rather...","market":"hk","thumbnail":"https://simplywall.st/cdn-cgi/image/fit=cover,format=auto,width=320,height=180/https://images.simplywall.st/asset/company-cover/29002-card/1789028982321","type":0,"news_type":0,"thumbnails":["https://simplywall.st/cdn-cgi/image/fit=cover,format=auto,width=320,height=180/https://images.simplywall.st/asset/company-cover/29002-card/1789028982321"],"rights":{"source":"simplywall_highlight","url":"https://simplywall.st/stocks/us/pharmaceuticals-biotech/nasdaq-gild/gilead-sciences/news/why-gilead-sciences-gild-is-back-in-the-spotlight","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://simplywall.st/stocks/us/pharmaceuticals-biotech/nasdaq-gild/gilead-sciences/news/why-gilead-sciences-gild-is-back-in-the-spotlight","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"simplywall_highlight","symbols":["IBBQ","LU1839511570.USD","LU0965509101.SGD","LU1057294990.SGD","LU0058720904.USD","LU0109394709.USD","LU2324357040.USD","LU1061106388.HKD","LU2112291526.USD","LU2087621335.USD","LU1430594728.SGD","LU1934455277.USD","LU0965509010.AUD","BK4588","LU2468319806.SGD","LU1236620750.USD","LU1037948897.HKD","LU0114720955.EUR","LU1066051498.USD","SG9999015986.USD","LU0965508806.USD","BBH","BMED","LU1571399168.USD","TBXU","BK4583","LU1674673428.USD","LU1236620834.HKD","SG9999015978.USD","LU0882574055.USD","LU1934455863.HKD","BK4585","GILD","LU1934455194.USD","IE00B3T34201.USD","LU0289739699.SGD","BK4568","IE00B7SZLL34.SGD","LU1037948541.HKD","IE00BSNM7G36.USD","MEDI","BK4532","BIB","LU0122379950.USD","LU1023059063.AUD","BK4139","IBB","LU1674673691.USD","IE00B19Z3B42.SGD","TMED"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2680972707","title":"Emergent BioSolutions trading resumes","url":"https://stock-news.laohu8.com/highlight/detail?id=2680972707","media":"TIPRANKS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2680972707?lang=en_us&edition=fundamental","pubTime":"2026-11-03 22:41","pubTimestamp":1793716868,"startTime":"0","endTime":"0","summary":"09:37 EST Emergent BioSolutions (EBS) trading resumes Published first on TheFly – the ultimate source for real-time, market-moving breaking financi...","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/the-fly/emergent-biosolutions-trading-resumes-thefly-news?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/the-fly/emergent-biosolutions-trading-resumes-thefly-news?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["EBS","BK4139","BK4583"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2680168727","title":"NYSE Halt Add Info Lst $6.455100","url":"https://stock-news.laohu8.com/highlight/detail?id=2680168727","media":"THOMSON REUTERS","labels":["event"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2680168727?lang=en_us&edition=fundamental","pubTime":"2026-11-03 22:32","pubTimestamp":1793716345,"startTime":"0","endTime":"0","summary":null,"market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20261103:nAQN2MRQ5O:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"event","news_rank":0,"length":0,"strategy_id":0,"source":"reuters_en_live","symbols":["BK4583","BK4139","EBS"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2680972904","title":"Emergent Shares Slide as 3Q Revenue Shrinks","url":"https://stock-news.laohu8.com/highlight/detail?id=2680972904","media":"Dow Jones","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2680972904?lang=en_us&edition=fundamental","pubTime":"2026-11-03 21:01","pubTimestamp":1793710860,"startTime":"0","endTime":"0","summary":"Shares of Emergent BioSolutions tumbled premarket after the maker of opioid overdose remedies and other emergency medications swung to a third-quarter loss due to a sharp drop in orders from the U.S. government and elsewhere.The company, which also makes antidotes for anthrax and other diseases, logged a loss of $32.7 million, or 64 cents a share, in contrast to a profit of $51.2 million, or 91 cents a share, a year earlier.Stripping out certain one-time items, Emergent posted an adjusted loss of 36 cents a share.Third-quarter revenue plunged 52% to $110 million. Revenue from Naloxone, the products preventing opioid overdoses, slid 42% to $43.5 million, on an adverse mix of sales via public-health outlets in the U.S.Revenue from smallpox products plunged 68% to $26.7 million, reflecting changes in timing of U.S. government orders.Emergent BioSolutions slashed its revenue projection to a range of $600 million to $645 million for the year from a previous $645 million-to-$675 million targ","market":"sg","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://dowjonesnews.com/newdjn/logon.aspx?AL=N","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4583","BK4139","EBS"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2680728789","title":"BioNTech Q3 2026 Swings to Net Profit of €184.5 Million","url":"https://stock-news.laohu8.com/highlight/detail?id=2680728789","media":"Reuters","labels":["corporation"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2680728789?lang=en_us&edition=fundamental","pubTime":"2026-11-03 19:46","pubTimestamp":1793706387,"startTime":"0","endTime":"0","summary":"BioNTech Q3 2026 swings to net profit of 184.5 millionBioNTech swung to a third-quarter 2026 net profit of 184.5 million from a year-earlier loss of 28.7 million.Revenues fell 15% year over year to 1.","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20261103:nNDL8hZ8hP:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"corporation","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["LU0314104364.USD","SG9999014021.USD","BNTX","BBH","IBBQ","LU1430594728.SGD","LU0889565916.HKD","LU1778281490.HKD","SG9999015978.USD","LU1674673691.USD","LU2087621335.USD","LU1066051498.USD","SG9999015952.SGD","IE00BQXX3C00.GBP","LU2324357040.USD","LU0289739699.SGD","IE00BQXX3D17.EUR","IBB","LU0058720904.USD","LU1037948897.HKD","TBXU","BMED","LU1934455277.USD","IE00BN0W2V16.EUR","NDAQ","SG9999014039.USD","IE00BKVL7J92.USD","GILD","BK4583","LU0859254822.USD","IE00BGHQF748.EUR","LU0965509101.SGD","SG9999015945.SGD","TMED","LU0823416689.USD","IE00BSNM7G36.USD","BK4578","BIB","BK4112","BK4548","BCDF","BK4566","LU1023059063.AUD","LU1839511570.USD","LU0114720955.EUR","LU1934455194.USD","LU2112291526.USD","MEDI","BK4588","IE00B3QW5Z07.USD"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2680739794","title":"Gilead Sciences Chairman and CEO Daniel Patrick O'Day Reports Sale of $5.33 Million in Common Shares","url":"https://stock-news.laohu8.com/highlight/detail?id=2680739794","media":"Reuters","labels":["insiderTrades"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2680739794?lang=en_us&edition=fundamental","pubTime":"2026-11-03 08:15","pubTimestamp":1793664947,"startTime":"0","endTime":"0","summary":"Gilead Sciences Chairman and CEO Daniel Patrick O'Day Reports Sale of $5.33 Million in Common SharesGilead Sciences Chairman and CEO Daniel Patrick O'Day sold 30,881 common shares on Oct. 30 and Nov. ","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20261103:nNDL3NDvQh:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":"Gilead Sciences Chairman and CEO Daniel Patrick O'Day Reports Sale of $5.33 Million in Common Shares","news_tag":"insiderTrades","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4139","LU0965508806.USD","BK4566","BK4532","GILD","MEDI","BK4578","LU0861579265.USD","LU2468319806.SGD","IBBQ","SG9999015952.SGD","LU1839511570.USD","BK4588","IE00BSNM7G36.USD","LU1061106388.HKD","LU0058720904.USD","BK4583","LU0320765992.SGD","LU1934455194.USD","IBB","LU1236620834.HKD","IE00BKVL7J92.USD","IE0002270589.USD","BBH","LU1037948541.HKD","LU1057294990.SGD","LU1778281490.HKD","TMED","IE00BZ1G4Q59.USD","LU2357627491.SGD","LU2324357040.USD","LU1585245621.USD","LU1571399168.USD","LU0965509283.SGD","LU2112291526.USD","SG9999015945.SGD","LU1934455277.USD","LU0109394709.USD","IE00B3T34201.USD","TBXU","LU0882574055.USD","LU0289739699.SGD","BMED","BIB","LU1674673691.USD","LU2089984988.USD","LU0889565916.HKD","LU0122379950.USD","LU0234570918.USD","SG9999015978.USD"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2680793748","title":"Inovio Schedules Third-Quarter Financial Results Release","url":"https://stock-news.laohu8.com/highlight/detail?id=2680793748","media":"Reuters","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2680793748?lang=en_us&edition=fundamental","pubTime":"2026-11-03 05:27","pubTimestamp":1793654871,"startTime":"0","endTime":"0","summary":"Inovio Schedules Third-Quarter Financial Results ReleaseInovio will release third-quarter 2026 financial results after market close on Nov. 10, 2026.A conference call and webcast will follow at 4:30 p","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20261102:nNDL2ZHLVD:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4139","BK4583","BK4568","INO"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2680939597","title":"Emergent BioSolutions Q3 Revenue Falls 52% on Lower Narcan Sales, Weaker Smallpox Product Revenue","url":"https://stock-news.laohu8.com/highlight/detail?id=2680939597","media":"Reuters","labels":["dataReport"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2680939597?lang=en_us&edition=fundamental","pubTime":"2026-11-03 05:18","pubTimestamp":1793654316,"startTime":"0","endTime":"0","summary":"Emergent BioSolutions Q3 revenue falls 52% on lower NARCAN sales, weaker smallpox product revenueOverviewUS biopharmaceutical firm's Q3 revenue fell 52% yr/yr, missing analyst expectationsCompany post","market":"sg","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20261102:nL2N46J0Z9:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"dataReport","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["EBS","BK4139","BK4583"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2680798059","title":"Emergent BioSolutions Names Frank Vargo Interim CFO Effective Jan. 1, 2027","url":"https://stock-news.laohu8.com/highlight/detail?id=2680798059","media":"Reuters","labels":["executive","event"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2680798059?lang=en_us&edition=fundamental","pubTime":"2026-11-03 05:13","pubTimestamp":1793653984,"startTime":"0","endTime":"0","summary":"Emergent BioSolutions Names Frank Vargo Interim CFO Effective Jan. 1, 2027Emergent BioSolutions Chief Financial Officer Rich Lindahl will retire effective December 31, 2026.Frank Vargo, vice president","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20261102:nNDL53J1h1:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"executive,event","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4583","EBS","BK4139"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2680980617","title":"Travere Q3 Product Sales Nearly Double on Filspari Growth","url":"https://stock-news.laohu8.com/highlight/detail?id=2680980617","media":"Reuters","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2680980617?lang=en_us&edition=fundamental","pubTime":"2026-11-03 05:12","pubTimestamp":1793653949,"startTime":"0","endTime":"0","summary":"Travere Q3 product sales nearly double on FILSPARI growthOverviewU.S. biopharma firm's Q3 product sales rose 95% yr/yr, driven by FILSPARI growthCompany posted Q3 net loss, reversing profit from prior","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20261102:nL2N46J0YV:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["LU0154245673.USD","TVTX","LFSC","LU0511384066.AUD","LU2324357040.USD","QURE","LU0689626769.HKD","LU0472753341.HKD","CMI","BK4583","LU0289961442.SGD","BK4149","LU0109394709.USD","LU0203345920.USD","IE000M9KFDE8.USD","BK4567","BK4585","LU2463526074.USD","MADE","LU0124676726.USD","LU0289739343.SGD","INO","LU0057025933.USD","BK4139","BK4588","LU0320765992.SGD","BK4568","LU0889565916.HKD","BK4533","LU0154245756.USD","LU0203347892.USD","LU0069063385.USD"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2680798111","title":"Emergent BioSolutions Q3 Revenue USD 110 Million","url":"https://stock-news.laohu8.com/highlight/detail?id=2680798111","media":"Reuters","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2680798111?lang=en_us&edition=fundamental","pubTime":"2026-11-03 05:06","pubTimestamp":1793653562,"startTime":"0","endTime":"0","summary":"BRIEF-Emergent BioSolutions Q3 Revenue USD 110 MillionNov 02 (Reuters) - Emergent BioSolutions Q3 gross margin 14%.Q3 adjusted EPS USD -0.36Q3 adjusted EBITDA USD -4.6 millionQ3 EPS USD -0.64Q3 net income USD -32.7 millionQ3 adjusted net income USD -18.7 millionQ3 adjusted gross margin 28%","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20261102:nPLXQLL5TL:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4583","BK4139","EBS"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2680798680","title":"Emergent BioSolutions Q3 EPS USD -0.64","url":"https://stock-news.laohu8.com/highlight/detail?id=2680798680","media":"THOMSON REUTERS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2680798680?lang=en_us&edition=fundamental","pubTime":"2026-11-03 05:05","pubTimestamp":1793653502,"startTime":"0","endTime":"0","summary":null,"market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20261102:nPLXQLL5TL:7","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"reuters_en_live","symbols":["BK4583","BK4139","EBS"],"isVideo":false,"video":null,"gpt_icon":0}],"profile":{"compareEarnings":[{"period":"1week","weight":-0.0199},{"period":"1month","weight":-0.0199},{"period":"3month","weight":-0.0201},{"period":"6month","weight":0.0311},{"period":"1year","weight":0.1039},{"period":"ytd","weight":0.1062}],"compareStock":{"symbol":"SPY","name":"SPDR S&P 500 ETF Trust"},"name":"BK4583","nameEN":"BK4583"},"APP":{"userAgent":"Mozilla/5.0 AppleWebKit/537.36 (KHTML, like Gecko; compatible; ClaudeBot/1.0; +claudebot@anthropic.com)","isDev":false,"isTTM":true,"isLaohu8Offline":false,"tenantId":"TBGLOBAL","deviceId":"web-server-community-laohu8-v3","version":"4.52.1","shortVersion":"4.52.1","platform":"web","vendor":"web","appName":"ttm","isIOS":false,"isAndroid":false,"isTiger":false,"isTHS":false,"isWeiXin":false,"isWeiXinMini":false,"isWeiBo":false,"isQQ":false,"isBaiduSwan":false,"isBaiduBox":false,"isDingTalk":false,"isToutiao":false,"isOnePlus":false,"isHuaWei":false,"isXiaomi":false,"isXiaomiWebView":false,"isOppo":false,"isVivo":false,"isSamsung":false,"isMobile":false},"pagemeta":{"title":"Monkeypox Concept(BK4583),Stock Price, Discussion, News, Quote & History - To The Moon - Tiger Brokers Online Investing Community","description":"Find the latest Monkeypox Concept(BK4583) stock quote, history, news, and investing ideas from To The Moon - Tiger Brokers Online Investing Community to stay on top of the markets.","keywords":"Monkeypox Concept,BK4583,Monkeypox Concept股票,Monkeypox Concept股票老虎,Monkeypox Concept股票老虎国际,Monkeypox Concept行情,Monkeypox Concept股票行情,Monkeypox Concept股价,Monkeypox Concept股市,Monkeypox Concept股票价格,Monkeypox Concept股票交易,Monkeypox Concept股票购买,Monkeypox Concept股票实时行情,购买美股,购买港股,港股开户,美股开户,美股交易,港股交易,开通美港股账户,老虎国际行情","social":{"og_title":"Monkeypox Concept(BK4583),Stock Price, Discussion, News, Quote & History - To The Moon - Tiger Brokers Online Investing Community","og_description":"Find the latest Monkeypox Concept(BK4583) stock quote, history, news, and investing ideas from To The Moon - Tiger Brokers Online Investing Community to stay on top of the markets.","og_image":"https://community-static.tradeup.com/news/9b6dafd60190235ae8e2c95f52c583a0"}}}